The development follows SAGE’s recommendations on 5 January on how the similar Pfizer COVID-19 vaccine should be used, as deaths from the new coronavirus topped 2.1 million globally. Both are so-called mRNA vaccines which trigger an immune response by teaching the body to make special proteins, as opposed to including any live or inactive weakened virus.
The WHO Strategic Advisory Group of Experts on Immunization has issued Interim recommendations for use of the Moderna mRNA-1273 vaccine against #COVID19 in people aged 18 years and older.
This is what you need to know: https://t.co/M7OQBCPclb
— World Health Organization (WHO) (@WHO) January 26, 2021
“Based on current evidence, SAGE recommends the administration of two doses – 100 micrograms, 0.5 millilitre each – with an interval of 28 days between doses”, said Dr Alejandro Cravioto, SAGE Chair. “SAGE recommends at present that, if judged necessary, due to exceptional circumstances of COVID-19